A phase 3 randomized, multicenter, double-blind study to evaluate the safety of upadacitinib in combination with topical corticosteroids in adolescent and adult patients with moderate-to-severe atopic dermatitis in Japan (Rising Up): An interim 24-week analysis

A phase 3 randomized, multicenter, double-blind study to evaluate the safety of upadacitinib in combination with topical corticosteroids in adolescent and adult patients with moderate-to-severe atopic dermatitis in Japan (Rising Up): An interim 24-week analysis

Systemic atopic dermatitis treatments that have acceptable safety are needed.To evaluate the safety of the oral Janus kinase inhibitor upadacitinib in combination with topical corticosteroids (TCSs) for the treatment of atopic dermatitis.In this phase 3, double-blind study (Rising Up), Japanese pati...

Бүрэн тодорхойлолт

-д хадгалсан:
Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид: Norito Katoh, Yukihiro Ohya, Hiroyuki Murota, Masanori Ikeda, Xiaofei Hu, Kimitoshi Ikeda, John Liu, Takuya Sasaki, Alvina D. Chu, Henrique D. Teixeira, Hidehisa Saeki
Формат: Artigo
Хэл сонгох:англи
Хэвлэсэн: 2021
Онлайн хандалт:https://doi.org/10.1016/j.jdin.2021.11.001
http://www.jaadinternational.org/article/S2666328721000894/pdf
Шошгууд: Шошго нэмэх
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!

Интернэт

https://doi.org/10.1016/j.jdin.2021.11.001
http://www.jaadinternational.org/article/S2666328721000894/pdf

Ижил төстэй зүйлс